Professors

Paul L. Bollyky, MD, PhD

Stanford University

Professor of Immunology/Microbiology

Stanford, CA

Dr Bollyky (pronounced “boy-key”) is a Professor of Immunology/Microbiology and an Infectious Disease physician at Stanford University.

Dr Bollyky is originally from Stanford, Connecticut. He received his DPhil at the University of Oxford, and his MD at Harvard Medical School. He completed his residency training at Brigham and Women’s Hospital and his Fellowship Training in Infectious Diseases at the University of Washington. Paul joined the Stanford University Medical School faculty in 2013. He is currently Associate Division Chief of the Division of Infectious Diseases and Co-Director of the Stanford Infectious Diseases Fellowship Program.

At Stanford, his lab studies bacteriophages and bacterial infections. His team is interested in understanding how phages in the human body contribute to health and disease and in using bacteriophages to treat chronic skin and lung infections.

(Updated July 18, 2024)

Joseph Bondy-Denomy, PhD

University of California San Francisco

Professor, Department of Microbiology & Immunology

San Francisco, CA

Dr Bondy-Denomy is a Professor in the Department of Microbiology & Immunology at the University of California San Francisco (UCSF). Prior to coming to UCSF, Dr Bondy-Denomy was a PhD student with Alan Davidson at the University of Toronto and received his undergraduate degree in Biology from the University of Waterloo. His lab is focused on studying the interactions between bacteriophages and the defense systems encoded by host bacteria, specifically focused on the human pathogen Pseudomonas aeruginosa. Historically, the lab has studied clustered regularly interspaced short palindromic repeats (CRISPR)-Cas systems and their inhibitors, anti-CRISPR proteins. More recent work has broadened that interest to include unique mechanisms of CRISPR-Cas evasion, such as “phage nucleus” compartments. The lab has also begun to characterize the immunity and anti-immunity mechanisms of Gabija, cyclic-oligonucleotide-based anti-phage signaling system (CBASS), Thoeris, Shango, and Jumbo phage killer defenses. Work in the Bondy-Denomy lab has been funded by the National Institutes of Health (NIH), Defense Advanced Research Projects Agency (DARPA), the Searle Scholars Program, the Vallee Foundation, and the Innovative Genomics Institute. Dr Bondy-Denomy serves as a reviewer for the NIH and other granting agencies and for many journals. He is also the cofounder of Acrigen Biosciences, a gene editing company using anti-CRISPR proteins, and on the scientific advisory board of SNIPR Biome, Leapfrog Bio, and Excision Biotherapeutics.

(Updated July 18, 2024)

David R. Boulware MD, MPH

University of Minnesota

McKnight Distinguished Professor, Infectious Disease & International Medicine

Minneapolis, MN

Timothy Brennan, MD, PhD

United States Food and Drug Administration

Silver Spring, MD, USA

John T. Brooks, MD

NIH/HIVMA/IDSA Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents With HIV

Co-Editor

Atlanta, GA

Marie T. Brown, MD

Rush University

Associate Professor, Department of Internal Medicine

Chicago, IL

Director, Practice Redesign
American Medical Association
Chicago, IL

Todd T. Brown, MD, PhD

The Johns Hopkins University

Professor of Medicine and Epidemiology

Baltimore, MD

R. Douglas Bruce, MD, MA, MS

MetroHealth

Senior Vice President, Chief Clinical Integration Officer

Cleveland, OH

Susan P. Buchbinder, MD

San Francisco Department of Public Health

Director, Bridge HIV

San Francisco, CA

Clinical Professor of Medicine and Epidemiology
University of California San Francisco
San Francisco, CA

Gary Bucher, MD

Anal Displasia Clinic MidWest

Chicago, IL